Clear Scientific Inc’s General Counsel, Winston Henderson, Joins Expert Panel on Tackling Substance Use Disorders

Boston, MA | July 2025

On July 31, Winston Henderson, General Counsel at Clear Scientific Inc., joined a panel with Carl Berke (Mass General Brigham Ventures), Michael Freni (AI Digital Innovation Fund), and moderator Sherene Shenouda (Mass General Brigham Innovation) to discuss funding innovation in the Substance Use Disorder (SUD) space. The panel explored how stakeholders—including investors, researchers, hospital leaders, and policymakers—can collaborate to advance and commercialize solutions to the SUD crisis.

Winston’s panel followed a session with Chris Coburn and Roger Kitterman of Mass General Brigham, with key insights from Elena Koustova (NIDA/NIH). These discussions were part of the SUD Sprint initiative, led by Babson College’s Murphy Healey Center and supported by NIDA, aimed at accelerating innovation in SUD prevention and treatment through cross-sector collaboration.

About Clear Scientific

Clear Scientific, co-founded by Prof. George Whitesides of Harvard University, is pioneering a new paradigm for treatment of conditions and diseases that involve an excess of specific compounds in the body. This approach focuses on development of highly selective, small molecule sequestrants that bind, immediately inactivates intoxicants, and rapidly clear excess compounds from the body.

For more information, visit https://www.clearsci.com.